Michael Tamm
- Diagnostic value of procalcitonin, CRP, leukocytes and BAL neutrophils for pulmonary complications in the immunocompromised hostBy Daiana Stolz, Andreas Stulz, Beat Mueller and Michael TammDaiana StolzAndreas StulzBeat Mueller
- Asthma and the regulated retrotransposon transcriptomeBy Nicola Miglino, Michael Roth, Florent Baty, Martin Brutsche, Michael Tamm and Pieter BorgerNicola Miglino*Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, BaselMichael Roth*Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, BaselFlorent Baty#Dept of Pneumology, Kantonsspital St Gallen, St Gallen, SwitzerlandMartin Brutsche#Dept of Pneumology, Kantonsspital St Gallen, St Gallen, SwitzerlandMichael Tamm*Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, BaselPieter Borger*Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel
- Dimethylfumarate inhibits CXCL10 via haem oxygenase-1 in airway smooth muscleBy Petra Seidel, Katrin E. Hostettler, J. Margaret Hughes, Michael Tamm and Michael RothPetra Seidel*Pulmonary Cell Research, Dept of Biomedicine and Pneumology, Dept of Internal Medicine, University Hospital Basel, Basel, Switzerland#Faculty of Pharmacy, University of Sydney, Sydney, AustraliaKatrin E. Hostettler*Pulmonary Cell Research, Dept of Biomedicine and Pneumology, Dept of Internal Medicine, University Hospital Basel, Basel, SwitzerlandJ. Margaret Hughes#Faculty of Pharmacy, University of Sydney, Sydney, AustraliaMichael Tamm*Pulmonary Cell Research, Dept of Biomedicine and Pneumology, Dept of Internal Medicine, University Hospital Basel, Basel, SwitzerlandMichael Roth*Pulmonary Cell Research, Dept of Biomedicine and Pneumology, Dept of Internal Medicine, University Hospital Basel, Basel, Switzerland
- Effect of fluticasone and formoterol combination therapy on airway remodelingBy Michael Roth, Jun Zhong, Chong S'ng and Michael TammMichael RothPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandJun ZhongPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandChong S'ngPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMichael TammPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, Switzerland
- Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantationBy Andreas Holbro, Jörg Halter, Spasenija Savic, Lukas Bubendorf, Dominik Heim, Martin Stern, Christoph Bucher, Jakob Passweg, Didier Lardinois and Michael TammAndreas Holbro1Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandJörg Halter1Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandSpasenija Savic2Department of Pathology, University Hospital Basel, Basel, SwitzerlandLukas Bubendorf2Department of Pathology, University Hospital Basel, Basel, SwitzerlandDominik Heim1Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandMartin Stern1Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandChristoph Bucher1Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandJakob Passweg1Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandDidier Lardinois3Clinic of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Tamm4Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Resistance pattern to WHO CAT IV regimen in patients suspected of drug resistance tuberculosis presenting to a specialist office practice in MumbaiBy Parag Chaudhari, Arvind Kate, Joerg Leuppi, Michael Tamm and Prashant ChhajedParag ChaudhariArvind KateJoerg Leuppi1Lung Care and Sleep Centre, Institute of Pulmonology, Medical Research and Development, Mumbai, Maharashtra, IndiaMichael Tamm1Lung Care and Sleep Centre, Institute of Pulmonology, Medical Research and Development, Mumbai, Maharashtra, India
- Behaviour of long-term weight following smoking cessationBy Andreas Scherr, Michael Tamm, Bruno Seiffert, Martin Kuster, Anja Meyer and Daiana StolzAndreas Scherr1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandMichael Tamm1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandBruno Seiffert2Industrial Health Service, F.Hoffmann-La Roche AG, Basel, SwitzerlandMartin Kuster3Industrial Health Service, Novartis Pharma AG, Basel, SwitzerlandAnja Meyer1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandDaiana Stolz1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, Switzerland
- Epigenetic deregulated translation control of C/EBP-alpha leads to increased mesothelioma cell proliferationBy Jun Zhong, Nicola Miglino, Michael Tamm, Didier Lardinois and Michael RothJun Zhong1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandNicola Miglino1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandDidier Lardinois2Thoracis Surgery, Universtity Hospital Basel, Basel, SwitzerlandMichael Roth1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, Switzerland
- Cigarette smoke down-regulates the expression of β-catenin in primary human lung fibroblastsBy Nicola Miglino, Seidel Petra, Michael Roth, Charlotte Sadowski-Cron, Didier Lardinois, Michael Tamm and Pieter BorgerNicola Miglino1Pulmonary Cell Research, Department Biomedicine, University Hospital Basel, Basel, SwitzerlandSeidel Petra1Pulmonary Cell Research, Department Biomedicine, University Hospital Basel, Basel, SwitzerlandMichael Roth1Pulmonary Cell Research, Department Biomedicine, University Hospital Basel, Basel, SwitzerlandCharlotte Sadowski-Cron2Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandDidier Lardinois2Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research, Department Biomedicine, University Hospital Basel, Basel, SwitzerlandPieter Borger1Pulmonary Cell Research, Department Biomedicine, University Hospital Basel, Basel, Switzerland
- Diagnostic surgical lung biopsy in hematologic patients with pulmonary complicationsBy Lilian Junker, Jörg Halter, Franco Gambazzi, Daiana Stolz, Lukas Bubendorf, Spasenija Savic, Dominik Heim, Martin Stern, Christoph Bucher, Didier Lardinois and Michael TammLilian Junker1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandJörg Halter2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandFranco Gambazzi3Department of Thoracic Surgery, Kantonsspital Aarau, Aarau, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandLukas Bubendorf4Department of Pathology, University Hospital Basel, Basel, SwitzerlandSpasenija Savic4Department of Pathology, University Hospital Basel, Basel, SwitzerlandDominik Heim2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandMartin Stern2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandChristoph Bucher2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandDidier Lardinois5Clinic of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Determinants of change in quality of life after smoking cessation of health care employeesBy Rebecca Finger, Michael Tamm, Bruno Seiffert, Martin Kuster, Anja Meyer and Daiana StolzRebecca Finger1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandMichael Tamm1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandBruno Seiffert2Industrial Health Service, F.Hoffmann-La Roche AG, Basel, SwitzerlandMartin Kuster3Industrial Health Service, Novartis Pharma AG, Basel, SwitzerlandAnja Meyer1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandDaiana Stolz1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, Switzerland
- The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC)By Michael Roth, Jun Zhong, Chong S'ng and Michael TammMichael RothPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandJun ZhongPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandChong S'ngPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMichael TammPulmonary Cell Research & Pneumology, University Hospital Basel, Basel, Switzerland
- Relation of health-related quality of life, frequent exacerbation phenotype and circulating systemic biomarkers in stable COPDBy Daiana Stolz, Francesco Blasi, Renaud Louis, Wim Boersma, Alicia Lacoma, Kostantinos Kostikas, Paola Castellotti, Lucas Boeck, Branislava Milenkovic, Tobias Welte, Janko Rakic, Emiel Wouters, Joachim Aerts, Arturo Huerta, Markos Minas, Antoni Torres and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandFrancesco Blasi2IRCCS Policlinico Milan, University of Milan, Milan, ItalyRenaud Louis3Pneumology, University of Liege, Liege, BelgiumWim Boersma4Pneumology, Medisch Centrum, Alkmaar, NetherlandsAlicia Lacoma5Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainKostantinos Kostikas6Pneumology, University of Thessaly Medical School, Larissa, GreecePaola Castellotti2IRCCS Policlinico Milan, University of Milan, Milan, ItalyLucas Boeck1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandBranislava Milenkovic7Institute for Pulmonary Diseases, Clinical Centre of Serbia, Belgrade, SerbiaTobias Welte8Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyJanko Rakic1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandEmiel Wouters9Pneumology, University Hospital Maastricht, Maastricht, NetherlandsJoachim Aerts10Pneumology, Amphia Hospital, Breda, NetherlandsArturo Huerta11Pneumology, Hospital Clinic, Barcelona, SpainMarkos Minas6Pneumology, University of Thessaly Medical School, Larissa, GreeceAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- Predictors of lung function improvement following smoking cessationBy Daiana Stolz, Rebecca Finger, Bruno Seiffert, Martin Kuster, Anja Meyer and Michael TammDaiana Stolz1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandRebecca Finger1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandBruno Seiffert2Industrial Health Service, F.Hoffmann-La Roche AG, Basel, SwitzerlandMartin Kuster3Industrial Health Service, Novartis Pharma AG, Basel, SwitzerlandAnja Meyer1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandMichael Tamm1Clinical of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, Switzerland
- Inhalation of a prostacyclin analog (iloprost) does not improve exercise capacity in COPD with disproportional pulmonary hypertensionBy Lucas Boeck, Michael Tamm and Daiana StolzLucas BoeckClinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael TammClinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana StolzClinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Neo-vascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patientsBy Laura Keglowich, Michael Roth, Michael Tamm and Peter BorgerLaura KeglowichPulmonary Cell Research & Pneumology, University Hospital, Basel, SwitzerlandMichael RothPulmonary Cell Research & Pneumology, University Hospital, Basel, SwitzerlandMichael TammPulmonary Cell Research & Pneumology, University Hospital, Basel, SwitzerlandPeter BorgerPulmonary Cell Research & Pneumology, University Hospital, Basel, Switzerland
- Cigarette smoke alters hyaluronic acid homeostasis in primary human lung fibroblastsBy Eleni Papakonstantinou, Ioannis Klagas, Nicola Miglino, George Karakiulakis, Michael Tamm and Michael RothEleni Papakonstantinou1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceNicola Miglino2Pulmonary Cell Research and Pneumology, Universtity Hospital Basel, Basel, SwitzerlandGeorge Karakiulakis1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Tamm2Pulmonary Cell Research and Pneumology, Universtity Hospital Basel, Basel, SwitzerlandMichael Roth2Pulmonary Cell Research and Pneumology, Universtity Hospital Basel, Basel, Switzerland
- Heme-oxygenase (HO)-1 inhibits TNF-α induced CXCL10 secretion by airway smooth muscle cellsBy Petra Seidel, Katrin Hostettler, Margaret Hughes, Michael Tamm and Michael RothPetra SeidelKatrin Hostettler1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMargaret Hughes2Respiratory Research Group, University of Sydney, Sydney, NSW, AustraliaMichael Tamm1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, Switzerland
- Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantationBy Katrin Hostettler, Jörg Halter, Didier Lardinois, Michael Roth and Michael TammKatrin Hostettler1Department of Biomedicine and Clinic of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandJörg Halter2Division of Hematology, University Hospital Basel, Basel, SwitzerlandDidier Lardinois3Clinic of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of Biomedicine and Clinic of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Biomedicine and Clinic of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Effects on adrenal function of a new combination of fluticasone propionate/formoterol fumarate administered to asthmatic patients and healthy subjectsBy Michael Tamm, Kirsten Kaiser, Brigit Grothe and Mark LomaxMichael Tamm1Department of Pneumology, University Hospital, Basel, SwitzerlandKirsten Kaiser2Clinical and Regulatory Development, SkyePharma AG, Muttenz, SwitzerlandBrigit Grothe3European Medical Science, Mundipharma Research Ltd., Cambridge, United KingdomMark Lomax3European Medical Science, Mundipharma Research Ltd., Cambridge, United Kingdom
- Long-term treatment with infliximab in patients with sarcoidosisBy Katrin Hostettler, Ueli Studler, Michael Tamm and Martin BrutscheKatrin Hostettler1Clinic of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandUeli Studler2Department of Radiology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMartin Brutsche1Clinic of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Tiotropium reduced carbachol-induced axpressions of IL-6 and IL-8 by primary human lung fibroblasts of asthma and non-asthma subjectsBy Luigi Costa, Michael Roth, Paola Casarosa, Michael Tamm and Pieter BorgerLuigi Costa1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, SwitzerlandMichael Roth1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, SwitzerlandPaola Casarosa2Respiratory Diseases Research, Boehringer Ingelheim Pharma, Biberach, GermanyMichael Tamm1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, SwitzerlandPieter Borger1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, Switzerland
- Aspergillus-PCR in bronchoalveolar lavage for detection of invasive fungal disease in immunocompromised patientsBy Michael Buess, Gieri Cathomas, Jörg Halter, Lilian Junker, Peter Grendelmeier, Michael Tamm and Daiana StolzMichael Buess1Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandGieri Cathomas2Department of Microbiology, Kanton Hospital Liestal, Liestal, SwitzerlandJörg Halter3Clinic for Hematology, University Hospital Basel, Basel, SwitzerlandLilian Junker1Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandPeter Grendelmeier1Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Airway reactivity to inhaled mannitol in young water pipe smokersBy Jérome Schmidlin, Silvio Albisser, Michael Tamm and Daiana StolzJérome SchmidlinClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandSilvio AlbisserClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael TammClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana StolzClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Change in perfusion patterns and its correlation to clinical outcomes following lung volume reduction surgery (LVRS) in COPD as assessed by single photon emission computer tomography (SPECT)By Henry Hoffmann, Didier Lardinois, Anke Mols, Anna-Maria Balestra, Flavio Forrer, Michael Tamm and Daiana StolzHenry Hoffmann1Clinic for Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandDidier Lardinois1Clinic for Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandAnke Mols1Clinic for Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandAnna-Maria Balestra2Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandFlavio Forrer3Clinic for Nuclear Medicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm2Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz2Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Omalizumab inhibits IgE-induced extracellular matrix deposition by asthmatic airway smooth muscle cellsBy Michael Roth and Michael TammMichael RothPnuemology, University Hospital Basel, Basel, SwitzerlandMichael TammPnuemology, University Hospital Basel, Basel, Switzerland
- Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPDBy Daiana Stolz, Wim Boersma, Renaud Louis, Francesco Blasi, Branislava Milenkovic, Alicia Lacoma, Joachim Aerts, Vincent Heinen, Marilena Pappalettera, Kostantinos Kostikas, Cristina Prat, Emiel Wouters, Antoni Torres, Tobias Welte and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsRenaud Louis3Pneumology, University of Liege, Liege, BelgiumFrancesco Blasi4IRCCS Policlinico Milan, University of Milan, Milan, ItalyBranislava Milenkovic5Institute for Pulmonary Diseases, Clinical Centre, Serbia, SerbiaAlicia Lacoma6Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainJoachim Aerts7Pneumology, Amphia Hospital, Breda, NetherlandsVincent Heinen3Pneumology, University of Liege, Liege, BelgiumMarilena Pappalettera4IRCCS Policlinico Milan, University of Milan, Milan, ItalyKostantinos Kostikas8Pneumology, University of Thessaly Medical School, Larissa, GreeceCristina Prat6Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainEmiel Wouters9Pneumology, University Hospital Maastricht, Maastricht, NetherlandsAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- Different expression pattern of endothelin receptors in primary human lung fibroblasts derived from idiopathic pulmonary fibrosis compared to healthy controlsBy Katrin Hostettler, Jun Zhong, Michael Tamm, Didier Lardinois and Michael RothKatrin Hostettler1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandJun Zhong1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandDidier Lardinois1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Pulmonary Cell Research & Pneumology, University Hospital Basel, Basel, Switzerland
- Epigenetic deregulated translation control of C/EBP-alpha leads to increased mesothelioma cell proliferationBy Jun Zhong, Nicola Miglino, Michael Tamm, Didier Lardinois, Lukas Bubendorf, John Szilard and Michael RothJun Zhong1Pulmonary Cell Research & Pneumology, Dept Research and Internal Medicine, University Hospital Basel, Basel, SwitzerlandNicola Miglino1Pulmonary Cell Research & Pneumology, Dept Research and Internal Medicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research & Pneumology, Dept Research and Internal Medicine, University Hospital Basel, Basel, SwitzerlandDidier Lardinois2Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandLukas Bubendorf3Dept. Pathology, University Hospital Basel, Basel, SwitzerlandJohn Szilard4The Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, AustraliaMichael Roth1Pulmonary Cell Research & Pneumology, Dept Research and Internal Medicine, University Hospital Basel, Basel, Switzerland
- Oxygen kinetics during 6-minute walk tests using mobile telemetric cardiopulmonary monitoringBy Lukas Kern, Sophie Condrau, Florent Baty, Wiegand Jan, Andrea Azzola, Michael Tamm and Martin BrutscheLukas Kern1Department of Pulmonary Medicine, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandSophie Condrau2Department of Internal Medicine, Regional Hospital, Interlaken, SwitzerlandFlorent Baty1Department of Pulmonary Medicine, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandWiegand Jan3Department of Critical Care Medicine, University Hospital Bern, Bern, SwitzerlandAndrea Azzola4Department of Pulmonary Medicine, Regional Hospital, Lugano, SwitzerlandMichael Tamm5Department of Pulmonary Medicine, University Hospital Basel, Basel, SwitzerlandMartin Brutsche1Department of Pulmonary Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
- Metapneumovirus pneumonia in allogeneic stemcell transplant recipientsBy Adrian Egli, Jörg Halter, Dominik Heim, Martin Stern, Christoph Bucher, Hans Hirsch and Michael TammAdrian Egli1Clinic of Hematology, University Hospital of Basel, Basel, SwitzerlandJörg Halter1Clinic of Hematology, University Hospital of Basel, Basel, SwitzerlandDominik Heim1Clinic of Hematology, University Hospital of Basel, Basel, SwitzerlandMartin Stern1Clinic of Hematology, University Hospital of Basel, Basel, SwitzerlandChristoph Bucher1Clinic of Hematology, University Hospital of Basel, Basel, SwitzerlandHans Hirsch2Clinic of Microbiology, University Hospital of Basel, Basel, SwitzerlandMichael Tamm3Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, Switzerland
- Pulmonary viral infection in hematologic patients with and without stemcell transplantationBy Lilian Junker, Jörg Halter, Alexis Dumoulin, Daiana Stolz, Dominik Heim, Martin Stern, Christoph Bucher, Jakob Passweg, Hans Hirsch and Michael TammLilian Junker1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandJörg Halter2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandAlexis Dumoulin3Institute for Microbiology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDominik Heim2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandMartin Stern2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandChristoph Bucher2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandJakob Passweg2Clinic of Hematology, University Hospital Basel, Basel, SwitzerlandHans Hirsch3Institute for Microbiology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Disease and stimulus specific pro-inflammatory cytokine secretion by human fibroblast of asthma patientsBy Luigi Costa, Pieter Borger, Paola Casarosa, Michael Tamm and Michael RothLuigi Costa1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, SwitzerlandPieter Borger1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, SwitzerlandPaola Casarosa2Respiratory Diseases Research, Boehringer Ingelheim Pharma, Biberach, GermanyMichael Tamm1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, SwitzerlandMichael Roth1Pulmonary Cell Research, Dept of Biomedicine, University Hospital Basel, Basel, BS, Switzerland
- Feasibility and safety of propofol sedation in flexible bronchoscopyBy Peter Grendelmeier, Gabriel Kurer, Eric Pflimlin, Michael Tamm and Daiana StolzPeter GrendelmeierClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandGabriel KurerClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandEric PflimlinClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael TammClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana StolzClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantationBy Katrin E. Hostettler, Jörg P. Halter, Sabine Gerull, Didier Lardinois, Spasenija Savic, Michael Roth and Michael TammKatrin E. Hostettler1Dept of Biomedicine, University Hospital Basel, Basel2Clinic of Respiratory Medicine, University Hospital Basel, BaselJörg P. Halter3Clinic of Hematology, University Hospital Basel, BaselSabine Gerull3Clinic of Hematology, University Hospital Basel, BaselDidier Lardinois4Clinic of Thoracic Surgery, University Hospital Basel, BaselSpasenija Savic5Institute for Pathology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Dept of Biomedicine, University Hospital Basel, BaselMichael Tamm1Dept of Biomedicine, University Hospital Basel, Basel2Clinic of Respiratory Medicine, University Hospital Basel, Basel
- Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” indexBy Daiana Stolz, Kostantinos Kostikas, Francesco Blasi, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim G. Aerts, Tobias Welte, Antoni Torres, Gernot G.U. Rohde, Lucas Boeck, Janko Rakic, Andreas Scherr, Sabine Hertel, Sven Giersdorf and Michael TammDaiana StolzKostantinos KostikasFrancesco BlasiWim BoersmaBranislava MilenkovicAlicia LacomaRenaud LouisJoachim G. AertsTobias WelteAntoni TorresGernot G.U. RohdeLucas BoeckJanko RakicAndreas ScherrSabine HertelSven Giersdorf
- Propofol sedation for flexible bronchoscopy: a randomised, noninferiority trialBy Peter Grendelmeier, Michael Tamm, Eric Pflimlin and Daiana StolzPeter GrendelmeierClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael TammClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandEric PflimlinClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana StolzClinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Whole-body magnetic resonance imaging in extrathoracic sarcoidosisBy Katrin E. Hostettler, Vlad A. Bratu, Arne Fischmann, Michael Tamm and Ulrich StudlerKatrin E. Hostettler1Clinic of Respiratory Medicine, University Hospital Basel, Basel3Both authors contributed equallyVlad A. Bratu2Dept of Radiology, University Hospital Basel, Basel, Switzerland3Both authors contributed equallyArne Fischmann2Dept of Radiology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Respiratory Medicine, University Hospital Basel, BaselUlrich Studler2Dept of Radiology, University Hospital Basel, Basel, Switzerland
- Propofol sedation for flexible bronchoscopy: A large randomized, controlled, non-inferiority trialBy Peter Grendelmeier, Eric Pflimlin, Michael Tamm and Daiana StolzPeter Grendelmeier1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandEric Pflimlin1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- Prospective international trial of endobronchial implantation of electromagnetic fiducials for real-time tracking of lung tumors during radiotherapy (RT)By Chris Bolliger, Daniel Nader, Felix Herth, Alexander Chen, Gerald Paris, Frank Zimmermann, Daniela Gompelmann, Michael Payne, Parag Parikh and Michael TammChris Bolliger1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaDaniel Nader1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaFelix Herth1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaAlexander Chen1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaGerald Paris1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaFrank Zimmermann1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaDaniela Gompelmann1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaMichael Payne1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaParag Parikh1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South AfricaMichael Tamm1Medicine, Faculty of Health Sciences, Tygerberg, Cape Town, South Africa
- Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patientsBy Luigi Costa, Michael Roth, Michael Tamm and Pieter BorgerLuigi Costa1Pulmonary Cell Research, Dept of Biomedicine, University Hospital, Basel, SwitzerlandMichael Roth1Pulmonary Cell Research, Dept of Biomedicine, University Hospital, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research, Dept of Biomedicine, University Hospital, Basel, SwitzerlandPieter Borger1Pulmonary Cell Research, Dept of Biomedicine, University Hospital, Basel, Switzerland
- Anti-fibrotic effects of nintedanib (BIBF 1120) in primary human lung fibroblasts derived from idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, George Karakiulakis, Michael Tamm, Didier Lardinois and Michael RothKatrin Hostettler1Department of Biomedicine, University Hospital, Basel, BS, SwitzerlandEleni Papakonstantinou2Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceIoannis Klagas2Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceGeorge Karakiulakis2Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceMichael Tamm3Clinic of Respiratory Medicine, University Hospital, Basel, BS, SwitzerlandDidier Lardinois4Division of Thoracic Surgery, University Hospital, Basel, BS, SwitzerlandMichael Roth1Department of Biomedicine, University Hospital, Basel, BS, Switzerland
- IgE-induced pro-inflammatory extracellular matrix composition in airway smooth muscle cells is prevented by omalizumabBy Michael Roth, Jun Zhong, Chong Teck S'ng and Michael TammMichael Roth1Pumonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandJun Zhong1Pumonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandChong Teck S'ng1Pumonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandMichael Tamm1Pumonary Cell Research, Dept. Biomedicine, University Hospital, Basel, Switzerland
- Combined assessment according to the new GOLD guidelines and its relation to outcome in COPDBy Daiana Stolz, Kostantinos Kostikas, Francesco Blasi, Branislava Milenkovic, Wim Boersma, Joachim Aerts, Renaud Louis, Tobias Welte, Alicia Lacoma, Cristina Prat, Andreas Scherr, Janko Rakic, Marilena Pappalettera, Gernot Rohde, Antoni Torres, Sabine Hertel, Sven Giersdorf and Michael TammDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandKostantinos Kostikas2University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi3Pneumology, IRCCS Policlinico, Milan, ItalyBranislava Milenkovic4Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma5Pneumology, Medisch Centrum, Alkmaar, NetherlandsJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsRenaud Louis7Pneumology, University of Liege, BelgiumTobias Welte8Pneumology, Medizinische Hochschule, Hannover, GermanyAlicia Lacoma9Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainCristina Prat9Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainAndreas Scherr1Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital, Basel, SwitzerlandMarilena Pappalettera3Pneumology, IRCCS Policlinico, Milan, ItalyGernot Rohde10Pneumology, University Hospital, Maastricht, NetherlandsAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainSabine Hertel12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- Seasonal variation of viral lower respiratory tract infections in immunocompromised patients undergoing diagnostic bronchoscopyBy Kathleen Jahn, Lilian Junker, Jörg Halter, Daiana Stolz and Michael TammKathleen Jahn1Clinic for Pneumology, University Hospital, Basel, SwitzerlandLilian Junker3Clinic for Pneumology, Hospital Thun, Thun, SwitzerlandJörg Halter2Clinic for Haematology, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic for Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic for Pneumology, University Hospital, Basel, Switzerland
- Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: “REDUCE*”, a non-inferiority multicenter trial. (*Reduction in the Use of Corticosteroids in Exacerbated COPD; ISRCTN19646069)By Jörg D. Leuppi, Philipp Schütz, Roland Bingisser, Matthias Briel, Tilman Drescher, Ursula Dürring, Christoph Henzen, Yolanda Leibbrandt, Sabrina Maier, David Miedinger, Beat Müller, Andreas Scherr, Christian Schindler, Rolf Stöckli, Sebastian Viatte, Christophe von Garnier, Michael Tamm and Jonas RutishauserJörg D. Leuppi1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandPhilipp Schütz2Clinic of Internal Medicine, Canton Hospital, Aarau, SwitzerlandRoland Bingisser3Interdisciplinary Emergency Department, University Hospital, Basel, SwitzerlandMatthias Briel4Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, SwitzerlandTilman Drescher1Clinic of Internal Medicine, University Hospital, Basel, Switzerland5Clinic for Endocrinology, Diabetology, and Clinical Nutrition, University Hospital, Basel, SwitzerlandUrsula Dürring5Clinic for Endocrinology, Diabetology, and Clinical Nutrition, University Hospital, Basel, SwitzerlandChristoph Henzen6Department of Internal Medicine, Canton Hospital, Luzern, SwitzerlandYolanda Leibbrandt7Clinic of Internal Medicine, Hospital Center, Biel-Bienne, SwitzerlandSabrina Maier1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandDavid Miedinger1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandBeat Müller2Clinic of Internal Medicine, Canton Hospital, Aarau, SwitzerlandAndreas Scherr1Clinic of Internal Medicine, University Hospital, Basel, Switzerland8Clinic for Pneumology, University Hospital, Basel, SwitzerlandChristian Schindler9Swiss Tropical and Public Health Institute, University of Basel, SwitzerlandRolf Stöckli5Clinic for Endocrinology, Diabetology, and Clinical Nutrition, University Hospital, Basel, SwitzerlandSebastian Viatte7Clinic of Internal Medicine, Hospital Center, Biel-Bienne, SwitzerlandChristophe von Garnier10Clinic of Pneumology, University Hospital, Bern, SwitzerlandMichael Tamm8Clinic for Pneumology, University Hospital, Basel, SwitzerlandJonas Rutishauser7Clinic of Internal Medicine, Hospital Center, Biel-Bienne, Switzerland
- Bacterial airway colonization is not associated with increased procalcitonin in stable COPDBy Daiana Stolz, Renaud Louis, Joachim Aerts, Tobias Welte, Alicia Lacoma, Wim Boersma, Kostantinos Kostikas, Francesco Blasi, Branislava Milenkovic, Cristina Prat, Janko Rakic, Lucas Boeck, Paola Castellotti, Gernot Rohde, Antoni Torres, Sabine Hertel, Sven Giersdorf and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandRenaud Louis2Pneumology, University of Liege, BelgiumJoachim Aerts3Pneumology, Amphia Hospital, Breda, NetherlandsTobias Welte4Pneumology, Medizinische Hochschule, Hannover, GermanyAlicia Lacoma5Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainWim Boersma6Pneumology, Medisch Centrum, Alkmaar, NetherlandsKostantinos Kostikas7University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi8Pneumology, IRCCS Policlinico, Milan, ItalyBranislava Milenkovic9Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaCristina Prat5Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainJanko Rakic1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandLucas Boeck1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandPaola Castellotti8Pneumology, IRCCS Policlinico, Milan, ItalyGernot Rohde10Pneumology, University Hospital, Maastricht, NetherlandsAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainSabine Hertel12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- The role of the regulated retrotransposon transcriptome in asthmaBy N. Miglino, M. Roth, Michael Tamm and P. BorgerN. Miglino1Department Biomedicine, University Hospital, Basel, SwitzerlandM. Roth1Department Biomedicine, University Hospital, Basel, SwitzerlandMichael Tamm1Department Biomedicine, University Hospital, Basel, SwitzerlandP. Borger1Department Biomedicine, University Hospital, Basel, Switzerland
- Lung resection in hematologic patients with pulmonary invasive fungal disease: Changing pattern in recent yearsBy Christian Nebiker, Didier Lardinois, Lilian Junker, Franco Gambazzi, Joerg Halter, Jakob Passweg, Daiana Stolz, Maja Weisser, Lukas Bubendorf, Alois Gratwohl and Michael TammChristian Nebiker1Division of Thoracic Surgery, University Hospital, Basel, SwitzerlandDidier Lardinois1Division of Thoracic Surgery, University Hospital, Basel, SwitzerlandLilian Junker2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandFranco Gambazzi1Division of Thoracic Surgery, University Hospital, Basel, SwitzerlandJoerg Halter3Division of Hematology, University Hospital, Basel, SwitzerlandJakob Passweg3Division of Hematology, University Hospital, Basel, SwitzerlandDaiana Stolz2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMaja Weisser4Division of Infectious Diseases & Hospital Epidemiology, University Hospital, Basel, SwitzerlandLukas Bubendorf5Department of Pathology, University Hospital, Basel, SwitzerlandAlois Gratwohl3Division of Hematology, University Hospital, Basel, SwitzerlandMichael Tamm2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patientsBy Laura Keglowich, Michael Roth, Maria Philippova, Thérèse J. Resink, Michael Tamm and Peter BorgerLaura Keglowich1Pulmonary Cell Research & Pneumology, University Hospital, Basel, SwitzerlandMichael Roth1Pulmonary Cell Research & Pneumology, University Hospital, Basel, SwitzerlandMaria Philippova2Signal Transduction, Department Biomedicine, University Hospital, Basel, SwitzerlandThérèse J. Resink2Signal Transduction, Department Biomedicine, University Hospital, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research & Pneumology, University Hospital, Basel, SwitzerlandPeter Borger1Pulmonary Cell Research & Pneumology, University Hospital, Basel, Switzerland
- Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, IndiaBy Prashant Chhajed, Arvind Kate, H.S. Sandeep, Parag Chaudhari, Santhakumar Subramanian, David Miedinger, Joerg Leuppi and Michael TammPrashant Chhajed1Pulmonology, Fortis-Hiranandani Hospital, Vashi, Navi Mumbai, Maharashtra, IndiaArvind Kate1Pulmonology, Fortis-Hiranandani Hospital, Vashi, Navi Mumbai, Maharashtra, IndiaH.S. Sandeep1Pulmonology, Fortis-Hiranandani Hospital, Vashi, Navi Mumbai, Maharashtra, IndiaParag Chaudhari1Pulmonology, Fortis-Hiranandani Hospital, Vashi, Navi Mumbai, Maharashtra, IndiaSanthakumar Subramanian1Pulmonology, Fortis-Hiranandani Hospital, Vashi, Navi Mumbai, Maharashtra, IndiaDavid Miedinger2Pulmonology, Institute of Pulmonology, Medical Research & Development, Mumbai, Maharashtra, IndiaJoerg Leuppi2Pulmonology, Institute of Pulmonology, Medical Research & Development, Mumbai, Maharashtra, IndiaMichael Tamm2Pulmonology, Institute of Pulmonology, Medical Research & Development, Mumbai, Maharashtra, India
- Lower respiratory tract infections in haematologic patients with and without stemcell transplantationBy Kathleen Jahn, Lilian Junker, Jörg Halter, Daiana Stolz and Michael TammKathleen Jahn1Clinic for Pneumology, University Hospital, Basel, SwitzerlandLilian Junker3Clinic for Pneumology, Clinic Thun, SwitzerlandJörg Halter2Clinic for Haematology, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic for Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic for Pneumology, University Hospital, Basel, Switzerland
- Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trialBy Andreas Scherr, Anja Jochmann, David Miedinger, Sabrina Maier, Salome Schafroth Török, Praschant Chhajed, Michael Tamm and Jörg LeuppiAndreas Scherr1Clinic of Internal Medicine, University Hospital, Basel, Switzerland2Clinic of Pneumology, University Hospital, Basel, SwitzerlandAnja Jochmann1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandDavid Miedinger1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandSabrina Maier1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandSalome Schafroth Török1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandPraschant Chhajed1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandMichael Tamm2Clinic of Pneumology, University Hospital, Basel, SwitzerlandJörg Leuppi1Clinic of Internal Medicine, University Hospital, Basel, Switzerland
- Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPDBy Andreas Scherr, Rolf Graf, Martha Bain, Miriam Christ-Crain, Beat Müller, Frederic Lajaunias, Michael Tamm and Daiana StolzAndreas Scherr1Clinic of Pneumology, University Hospital, Basel, SwitzerlandRolf Graf2Pancreatitis Research Laboratory, University Hospital, Zürich, SwitzerlandMartha Bain2Pancreatitis Research Laboratory, University Hospital, Zürich, SwitzerlandMiriam Christ-Crain3Clinic of Endocrinology, University Hospital, Basel, SwitzerlandBeat Müller4Internal Medicine, Hospital of Aarau, Argovia, SwitzerlandFrederic Lajaunias5LASCCO SA Geneva, LASCCO, Geneva, SwitzerlandMichael Tamm1Clinic of Pneumology, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic of Pneumology, University Hospital, Basel, Switzerland
- Differences between commercial vehicle drivers and other patients in symptoms of obstructive sleep apnoea and response to CPAP therapyBy Werner Strobel, Daiana Stolz and Michael TammWerner Strobel1Pneumology, University Hospital, Basel, SwitzerlandDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- Formoterol reduces asthmatic airway smooth muscle cell proliferation through p27 (Kip) which is supported by steroidsBy Michael Roth, Jun Zhong, Pieter Borger, Chong Teck S'ng and Michael TammMichael Roth1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandJun Zhong1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandPieter Borger1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandChong Teck S'ng1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, Switzerland
- Whole-body magnetic resonance imaging in sarcoidosis to assess extrapulmonary organ involvementBy Katrin Hostettler, Ueli Studler, Vlad Bratu, Arne Fischmann and Michael TammKatrin Hostettler1Clinic of Respiratory Medicine, University Hospital, Basel, BS, SwitzerlandUeli Studler2Department of Radiology, University Hospital, Basel, BS, SwitzerlandVlad Bratu2Department of Radiology, University Hospital, Basel, BS, SwitzerlandArne Fischmann2Department of Radiology, University Hospital, Basel, BS, SwitzerlandMichael Tamm1Clinic of Respiratory Medicine, University Hospital, Basel, BS, Switzerland
- Formoterol and fluticasone reduce the deposition of pro-inflammatory collagensBy Michael Roth, Jun Zhong, Chong Teck S'ng and Michael TammMichael Roth1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandJun Zhong1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandChong Teck S'ng1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, SwitzerlandMichael Tamm1Pulmonary Cell Research, Dept. Biomedicine, University Hospital, Basel, Switzerland
- Prediction of mortality in the Swiss chronic obstructive pulmonary disease (COPD) cohort using the age dyspnoe and airflow obstruction index (ADO)By Lucia Schönenberger, Anja Jochmann, Pierre-Olivier Bridevaux, Prashant N. Chhajed, Jean-William Fitting, Thomas Geiser, Malcolm Kohler, Sabrina Maier, David Miedinger, Salome Schafroth Török, Andreas Scherr, Robert Thurnheer, Michael Tamm and Jörg D. LeuppiLucia Schönenberger1Internal Medicine, University Hospital, Basel, SwitzerlandAnja Jochmann1Internal Medicine, University Hospital, Basel, SwitzerlandPierre-Olivier Bridevaux2Pneumology, University Hospital, Geneva, SwitzerlandPrashant N. Chhajed1Internal Medicine, University Hospital, Basel, SwitzerlandJean-William Fitting3Pneumology, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandThomas Geiser4Pneumology, University Hospital, Bern, SwitzerlandMalcolm Kohler5Pneumology, University Hospital, Zurich, SwitzerlandSabrina Maier1Internal Medicine, University Hospital, Basel, SwitzerlandDavid Miedinger1Internal Medicine, University Hospital, Basel, SwitzerlandSalome Schafroth Török1Internal Medicine, University Hospital, Basel, SwitzerlandAndreas Scherr1Internal Medicine, University Hospital, Basel, SwitzerlandRobert Thurnheer6Internal Medicine, Kantonsspital Münsterlingen, Münsterlingen, SwitzerlandMichael Tamm1Internal Medicine, University Hospital, Basel, SwitzerlandJörg D. Leuppi1Internal Medicine, University Hospital, Basel, Switzerland
- Interdependence of endothelin-1 and transforming growth factor-β1 on Wnt3a expression in idiopathic pulmonary fibrosisBy Jun Zhong, Michael Roth, Michael Tamm, Didier Lardinois and Katrin HostettlerJun Zhong1Department of Biomedicine, University Hospital, Basel, BS, SwitzerlandMichael Roth1Department of Biomedicine, University Hospital, Basel, BS, SwitzerlandMichael Tamm2Clinic of Respiratory Medicine, University Hospital, Basel, BS, SwitzerlandDidier Lardinois3Division of Thoracic Surgery, University Hospital, Basel, BS, SwitzerlandKatrin Hostettler1Department of Biomedicine, University Hospital, Basel, BS, Switzerland
- Identification of bacterial pulmonary infection by a PCR based rapid molecular diagnostic assay in bronchoalveolar lavageBy Kathleen Jahn, Michael Tamm, Minna Maki, Marko Kuisma and Daina StolzKathleen Jahn1Clinic of Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic of Pneumology, University Hospital, Basel, SwitzerlandMinna Maki2Mobidiag Ltd, Tukholmankatu 8/Biomedicum 2U, Helsinki, FinlandMarko Kuisma2Mobidiag Ltd, Tukholmankatu 8/Biomedicum 2U, Helsinki, FinlandDaina Stolz1Clinic of Pneumology, University Hospital, Basel, Switzerland
- Evidence of increased pluripotent cells in adult human lung tissue derived from fibrotic lungs compared to non-fibrotic control lungsBy Katrin Hostettler, Amiq Gazdhar, Thomas Geiser, Michael Tamm, Didier Lardinois and Michael RothKatrin Hostettler1Department of Biomedicine, University Hospital, Basel, BS, SwitzerlandAmiq Gazdhar2Division of Pulmonary Medicine, University Hospital, Bern, BE, SwitzerlandThomas Geiser2Division of Pulmonary Medicine, University Hospital, Bern, BE, SwitzerlandMichael Tamm3Clinic of Respiratory Medicine, University Hospital, Basel, BS, SwitzerlandDidier Lardinois4Division of Thoracic Surgery, University Hospital, Basel, BS, SwitzerlandMichael Roth1Department of Biomedicine, University Hospital, Basel, BS, Switzerland
- Adenovirus IgG avidity - A marker of outcome in COPD-exacerbationsBy Lucas Boeck, Mesut Gencay, Michael Tamm, Mirjam Christ-Crain, Beat Mueller, Michael Roth and Daiana StolzLucas Boeck1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMesut Gencay1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMirjam Christ-Crain2Endocrinology, University Hospital, Basel, SwitzerlandBeat Mueller3Internal Medicine, Kanton Hospital, Aarau, SwitzerlandMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Proadrenomedullin improves the prognostic property of the BODE indexBy Daiana Stolz, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Renaud Louis, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Antoni Torres, Tobias Welte, Oliver Hartmann, Sven Giersdorf and Michael TammDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsRenaud Louis7Pneumology, University of Liege, BelgiumGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital, Basel, SwitzerlandAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyOliver Hartmann12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPDBy Eleni Papakonstantinou, Michael Tamm, Michael Roth and Daiana StolzEleni Papakonstantinou1Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceMichael Tamm2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMichael Roth2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandDaiana Stolz2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Propofol sedation for flexible bronchoscopy in patients with and without chronic obstructive pulmonary diseaseBy Daiana Stolz, Peter Grendelmeier, Kathleen Jahn and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Propofol sedation for EBUS-TBNA in flexible bronchoscopyBy Peter Grendelmeier, Jean-Marie Tschopp, Martin Brutsche, Florian Charbonnier, Jean-Georges Frey, Tino Schneider, Jean-Marie Schnyder, Michael Tamm and Daiana StolzPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandJean-Marie Tschopp2Centre Valaisan De Pneumologie, Hôpital Du Valais, Crans-Montana, SwitzerlandMartin Brutsche3Clinic of Pulmonary Medicine, Kantonsspital St. Gallen, St. Gallen, SwitzerlandFlorian Charbonnier2Centre Valaisan De Pneumologie, Hôpital Du Valais, Crans-Montana, SwitzerlandJean-Georges Frey2Centre Valaisan De Pneumologie, Hôpital Du Valais, Crans-Montana, SwitzerlandTino Schneider3Clinic of Pulmonary Medicine, Kantonsspital St. Gallen, St. Gallen, SwitzerlandJean-Marie Schnyder2Centre Valaisan De Pneumologie, Hôpital Du Valais, Crans-Montana, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPDBy Lucas Boeck, Mikael Gencay, Michael Roth, Hans Hirsch, Mirjam Christ-Crain, Beat Müller, Michael Tamm and Daiana StolzLucas Boeck1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandMikael Gencay1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandHans Hirsch2Transplantation and Clinical Virology, Department of Biomedicine, University Basel, Basel, SwitzerlandMirjam Christ-Crain3Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, SwitzerlandBeat Müller4Medical University Department, Kantonsspital Aarau, Aarau, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
- Vasopressin, atrial natriuretic peptide and adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnoea syndromeBy Peter Grendelmeier, Werner Strobel, Thomas Schmid, Kathleen Jahn, Michael Tamm and Daiana StolzPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandWerner Strobel1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandThomas Schmid2Lungenpraxis, Werkhofstrasse 4, Solothurn, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Antibiotic utilisation and indication during mechanical ventilation in surgical and medical ICU patientsBy Lucas Boeck, Hans Pargger, Peter Schellongowski, Charles-Edouard Luyt, Marco Maggiorini, Maurizio Bernasconi, Kathleen Jahn, Jean Chastre, Rene Lötscher, Evelyne Bucher, Nadine Cueni, Michael Koller, Annekathrin Mehlig, Thomas Staudinger, Heiner Bucher, Michael Tamm and Daiana StolzLucas Boeck1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandHans Pargger2Department for Anaesthesiology and Surgical Intensive Care Medicine, University Hospital Basel, Basel, SwitzerlandPeter Schellongowski3Department of Internal Medicine I, University Hospital Vienna, Vienna, AustriaCharles-Edouard Luyt4Service De Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris, FranceMarco Maggiorini5Department of Internal Medicine, Intensive Care Unit, University Hospital Zürich, Zürich, SwitzerlandMaurizio Bernasconi6Intensive Care Medicine, Hospital Civico, Lugano, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandJean Chastre4Service De Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris, FranceRene Lötscher7Surgical and Medical Intensive Care Medicine, Kantonsspital Baselland, Liestal, SwitzerlandEvelyne Bucher2Department for Anaesthesiology and Surgical Intensive Care Medicine, University Hospital Basel, Basel, SwitzerlandNadine Cueni2Department for Anaesthesiology and Surgical Intensive Care Medicine, University Hospital Basel, Basel, SwitzerlandMichael Koller8Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, SwitzerlandAnnekathrin Mehlig7Surgical and Medical Intensive Care Medicine, Kantonsspital Baselland, Liestal, SwitzerlandThomas Staudinger3Department of Internal Medicine I, University Hospital Vienna, Vienna, AustriaHeiner Bucher8Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
- Effect of hypoxia on proliferation and VEGF-release of human bronchial smooth muscle cellsBy Laura Keglowich, Michael Roth, Michael Tamm and Pieter BorgerLaura Keglowich1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandMichael Roth1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandMichael Tamm2Internal Medicine - Pneumology, University Hospital Basel, Basel, SwitzerlandPieter Borger1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, Switzerland
- Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbationBy Eleni Papakonstantinou, Michael Roth, George Karakiulakis, Spasenija Savic, Michael Tamm and Daiana StolzEleni Papakonstantinou1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Roth2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandGeorge Karakiulakis1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceSpasenija Savic3Department of Pathology, University Hospital Basel, Basel, SwitzerlandMichael Tamm2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Cigarette smoke extract induces activity of the transposable element LINE1 in primary human lung fibroblastsBy Nicola Miglino, Michael Tamm, Michael Roth and Pieter BorgerNicola Miglino1Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandPieter Borger1Department of Biomedicine, University Hospital Basel, Basel, Switzerland
- Propofol versus midazolam for conscious sedation in medical thoracoscopy: A randomized non-inferiority trialBy Peter Grendelmeier, Eric Pflimlin, Michael Tamm and Daiana StolzPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandEric Pflimlin1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Primary human lung fibroblasts of asthma patients proliferate significantly faster than those of controls in response to muscarinic receptor stimulation with carbacholBy Luigi Costa, Michael Roth, Michael Tamm and Pieter BorgerLuigi Costa1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandMichael Roth1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandMichael Tamm2Internal Medicine - Pneumology, University Hospital Basel, Basel, SwitzerlandPieter Borger1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, Switzerland
- Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic propertiesBy Katrin Hostettler, Laura Keglowich, Thomas Geiser, Michael Tamm, Didier Lardinois, Michael Roth and Amid GazdharKatrin Hostettler1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandLaura Keglowich1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandThomas Geiser2Division of Pulmonary Medicine, University Hospital Bern, Bern, SwitzerlandMichael Tamm3Pneumology, University Hospital Basel, Basel, SwitzerlandDidier Lardinois4Division of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Roth1Dept. Biomedicine/Pumonary Cell Research, University of Basel, Basel, SwitzerlandAmid Gazdhar2Division of Pulmonary Medicine, University Hospital Bern, Bern, Switzerland
- Factors associated with exacerbation in a general practitioners'-based Swiss chronic obstructive pulmonary disease (COPD) cohortBy Nebal Abu Hussein, Pierre-Olivier Bridevaux, Prashant Chhajed, Jean-William Fitting, Thomas Geiser, Ladina Joos Zellweger, Malcolm Kohler, Sabrina Maier, David Miedinger, Salome Schafroth Török, Robert Thurnheer, Michael Tamm and Jörg Daniel LeuppiNebal Abu Hussein1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, SwitzerlandPierre-Olivier Bridevaux2Service De Pneumologie, Hôpitaux Universitaires De Genève, Geneva, SwitzerlandPrashant Chhajed1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, SwitzerlandJean-William Fitting3Département De Médecine Interne, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandThomas Geiser4Universitätsklinik Für Pneumologie, Inselspital Bern, Bern, SwitzerlandLadina Joos Zellweger5Department of Pneumology, Claraspital Basel, Basel, SwitzerlandMalcolm Kohler6Clinic of Pneumology, University Hospital Zurich, Zurich, SwitzerlandSabrina Maier1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, SwitzerlandDavid Miedinger1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, SwitzerlandSalome Schafroth Török1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, SwitzerlandRobert Thurnheer7Department of Internal Medicine, Kantonsspital Münsterlingen, Münsterlingen, SwitzerlandMichael Tamm1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, SwitzerlandJörg Daniel Leuppi1Clinic of Internal Medicine, Unversity Hospital Basel, Basel, Switzerland
- Dimethylfumarate inhibits CXCL10 via heme-oxygenase-1 in airway smooth muscleBy P Seidel, KE Hostettler, JM Hughes, M Tamm and Michael RothArticle | Published in 2012 in European Respiratory JournalP SeidelKE HostettlerJM HughesM TammMichael Roth
- Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantationBy Katrin E Hostettler, Jörg P. Halter, Sabine Gerull, Didier Lardinois, Spasenija Savic, Michael Roth and Michael TammArticle | Published in 2013 in European Respiratory JournalKatrin E Hostettler*Dept of Biomedicine, University Hospital Basel, Basel 4031, Switzerland#Clinic of Respiratory Medicine, University Hospital Basel, Basel 4031, SwitzerlandJörg P. Halter¶Clinic of Hematology, University Hospital Basel, Basel 4031, SwitzerlandSabine Gerull¶Clinic of Hematology, University Hospital Basel, Basel 4031, SwitzerlandDidier Lardinois+Clinic of Thoracic Surgery, University Hospital Basel, Basel 4031, SwitzerlandSpasenija Savic§Institute for Pathology, University Hospital Basel, Basel 4031, SwitzerlandMichael Roth*Dept of Biomedicine, University Hospital Basel, Basel 4031, SwitzerlandMichael Tamm*Dept of Biomedicine, University Hospital Basel, Basel 4031, Switzerland#Clinic of Respiratory Medicine, University Hospital Basel, Basel 4031, Switzerland
- Adrenomedullin refines mortality prediction by the BODE index in COPD – The “BODE-A” indexBy Daiana Stolz, Kostantinos Kostikas, Francesco Blasi, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim G. Aerts, Tobias Welte, Antoni Torres, Gernot G.U. Rohde, Lucas Boeck, Janko Rakic, Andreas Scherr, Sabine Hertel, Sven Giersdorf and Michael TammArticle | Published in 2013 in European Respiratory JournalDaiana Stolz*Dept of Pneumology, University Hospital, Basel, SwitzerlandKostantinos Kostikas#Dept of Pneumonology, University Thessaly Medical School, Larissa, GreeceFrancesco Blasi¶Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalyWim Boersma+Dept of Pneumology, Medisch Centrum Alkmaar, Alkmaar, The NetherlandsBranislava Milenkovic§Dept of Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaAlicia LacomafDept of Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainRenaud Louis**Dept of Pneumology, CHU Liege, University of Liege, GIGAI Research Group, Liege, BelgiumJoachim G. Aerts##Dept of Pneumology, Amphia Hospital/Erasmus MC, Breda, The NetherlandsTobias Welte¶¶Dept of Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyAntoni Torres++Dept of Pneumology, Hospital Clinic, Barcelona, SpainGernot G.U. Rohde§§Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The NetherlandsLucas Boeck*Dept of Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic*Dept of Pneumology, University Hospital, Basel, SwitzerlandAndreas Scherr*Dept of Pneumology, University Hospital, Basel, SwitzerlandSabine HertelffClinical Diagnostics Division, Thermo Scientific Biomarkers, B·R·A·H·M·S GmbH, Hennigsdorf, GermanySven GiersdorfffClinical Diagnostics Division, Thermo Scientific Biomarkers, B·R·A·H·M·S GmbH, Hennigsdorf, GermanyMichael Tamm*Dept of Pneumology, University Hospital, Basel, Switzerland
- Propofol sedation for flexible bronchoscopy: randomized, non-inferiority trialBy Peter Grendelmeier, Michael Tamm, Eric Pflimlin and Daiana StolzArticle | Published in 2013 in European Respiratory JournalPeter Grendelmeier*Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, SwitzerlandMichael Tamm*Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, SwitzerlandEric Pflimlin*Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, SwitzerlandDaiana Stolz*Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Switzerland
- Whole-body magnetic resonance imaging in extrathoracic sarcoidosisBy Katrin E. Hostettler, Vlad A. Bratu, Arne Fischmann, Michael Tamm and Ulrich StudlerArticle | Published in 2014 in European Respiratory JournalKatrin E. Hostettler1Clinic of Respiratory Medicine, University Hospital Basel, Basel,3Both authors contributed equally,Vlad A. Bratu2Dept of Radiology, University Hospital Basel, Basel, Switzerland3Both authors contributed equally,Arne Fischmann2Dept of Radiology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Respiratory Medicine, University Hospital Basel, Basel,Ulrich Studler2Dept of Radiology, University Hospital Basel, Basel, Switzerland
- Mortality risk prediction in COPD by a prognostic biomarker panelBy Daiana Stolz, Anja Meyer, Janko Rakic, Lucas Boeck, Andreas Scherr and Michael TammArticle | Published in 2014 in European Respiratory JournalDaiana StolzClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandAnja MeyerClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandJanko RakicClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandLucas BoeckClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandAndreas ScherrClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMichael TammClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, Switzerland
- The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infectionBy Daiana Stolz, Wim Boersma, Francesco Blasi, Renaud Louis, Joachim Aerts, Tobias Welte, Alicia Lacoma, Kostantinos Kostikas, Branislava Milenkovic, Alicia Marin, Janko Rakic, Lucas Boeck, Paola Castellotti, Gernot G.U. Rohde, Antoni Torres, Sabine Hertel, Sven Giersdorf and Michael TammDaiana Stolz1Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsFrancesco Blasi3Pneumology, IRCCS Policlinico, Milan, ItalyRenaud Louis4Pneumology, University of Liege, Liege, BelgiumJoachim Aerts5Pneumology, Amphia Hospital, Breda, NetherlandsTobias Welte6Pneumology, Medizinische Hochschule, Hannover, GermanyAlicia Lacoma7Microbiology, Hospital Universitari Germans Trias I Pujol, Badalona, SpainKostantinos Kostikas8University, Thessaly Medical School, Thessaloniki, GreeceBranislava Milenkovic9Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaAlicia Marin7Microbiology, Hospital Universitari Germans Trias I Pujol, Badalona, SpainJanko Rakic13Pneumology, Hospital of Aarau, Aarau, SwitzerlandLucas Boeck1Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandPaola Castellotti3Pneumology, IRCCS Policlinico, Milan, ItalyGernot G.U. Rohde10Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, NetherlandsAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainSabine Hertel12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Mortality risk prediction in COPD by a prognostic biomarker panelBy Daiana Stolz, Anja Meyer, Janko Rakic, Lucas Boeck, Andreas Scherr and Michael TammArticle | Published in 2014 in European Respiratory JournalDaiana StolzClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandAnja MeyerClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandJanko RakicClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandLucas BoeckClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandAndreas ScherrClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMichael TammClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Mortality risk prediction in COPD by a prognostic biomarker panelBy Daiana Stolz, Anja Meyer, Janko Rakic, Lucas Boeck, Andreas Scherr and Michael TammDaiana StolzClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandAnja MeyerClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandJanko RakicClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandLucas BoeckClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandAndreas ScherrClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMichael TammClinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Adrenomedullin optimizes mortality prediction in COPDBy Marjolein Brusse-Keizer, Maaike Zuur-Telgen, Job van der Palen, Paul vanderValk, Huib Kerstjens, Wim Boerrsma, Francesco Blasi, Kostantinos Kostikas, Branislava Milenkovic, Michael Tamm and Daiana StolzMarjolein Brusse-Keizer1Medical School Twente, Medisch Spectrum Twente, Enschede, NetherlandsMaaike Zuur-Telgen2Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, NetherlandsJob van der Palen1Medical School Twente, Medisch Spectrum Twente, Enschede, Netherlands3Department of Research Methodology, Measurement, and Data analysis, University of Twente, Enschede, NetherlandsPaul vanderValk2Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, NetherlandsHuib Kerstjens4Department of Pulmonary Medicine, and Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Centre Groningen, Groningen, NetherlandsWim Boerrsma5Department of Pneumology, Medisch Centrum Alkmaar, Alkmaar, NetherlandsFrancesco Blasi6Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalyKostantinos Kostikas7Department of Pneumonology, University Thessaly Medical School, Larissa, GreeceBranislava Milenkovic8Department of Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaMichael Tamm9Department of Pneumology, Hospital Basel, Basel, SwitzerlandDaiana Stolz9Department of Pneumology, Hospital Basel, Basel, Switzerland
- Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-upBy Stolz Daiana, Anja Meyer, Janko Rakic, Lucas Boeck, Andreas Scherr and Michael TammStolz Daiana1Pneumology, University Hospital of Basel, Basel, SwitzerlandAnja Meyer1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPDBy Michael Roth, Daiana Stolz, Eleni Papakonstantinou, Ioannis Bonovolias, George Karakiulakis and Michael TammMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandIoannis Bonovolias2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, SwitzerlandGeorge Karakiulakis2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Effect of pirfenidone on TGF-β-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Jun Zhong, Michael Tamm, Didier Lardinois and Michael RothKatrin Hostettler1Department of BioMedicine, University Hospital Basel, Basel, Switzerland2Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandJun Zhong1Department of BioMedicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of BioMedicine, University Hospital Basel, Basel, Switzerland2Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandDidier Lardinois3Division of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of BioMedicine, University Hospital Basel, Basel, Switzerland
- Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPDBy Daiana Stolz, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr and Michael TammDaiana Stolz1Pneumology, University Hospital of Basel, Basel, SwitzerlandTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainRenaud Louis7Pneumology CHU Liege, University of Liege, Liege, BelgiumWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrad, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- The association of „normal glucose“ with outcome in mechanically ventilated ICU patientsBy Lucas Boeck, Hans Pargger, Peter Schellongowski, Charles-Edouard Luyt, Marco Maggiorini, Maurizio Bernasconi, Kathleen Jahn, Jean Chastre, Rene Lötscher, Evelyne Bucher, Nadine Cueni, Michael Koller, Annekathrin Mehlig, Thomas Staudinger, Heiner Bucher, Michael Tamm and Daiana StolzLucas Boeck1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandHans Pargger2Department of Anaesthesia and Surgical Intensive Care Medicine, University Hospital Basel, Basel, SwitzerlandPeter Schellongowski3Department of Internal Medicine I, University Hospital Vienna, Vienna, AustriaCharles-Edouard Luyt4Service de Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris, FranceMarco Maggiorini5Department of Internal Medicine, Intensive Care Unit, University Hospital Zürich, Zürich, SwitzerlandMaurizio Bernasconi6Intensive Care Medicine, Hospital Civico, Lugano, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandJean Chastre4Service de Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris, FranceRene Lötscher7Surgical and Medical Intensive Care Medicine, Kantonsspital Baselland, Liestal, SwitzerlandEvelyne Bucher2Department of Anaesthesia and Surgical Intensive Care Medicine, University Hospital Basel, Basel, SwitzerlandNadine Cueni2Department of Anaesthesia and Surgical Intensive Care Medicine, University Hospital Basel, Basel, SwitzerlandMichael Koller8Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, SwitzerlandAnnekathrin Mehlig7Surgical and Medical Intensive Care Medicine, Kantonsspital Baselland, Liestal, SwitzerlandThomas Staudinger3Department of Internal Medicine I, University Hospital Vienna, Vienna, AustriaHeiner Bucher8Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
- Omalizumab prevents smooth muscle cell growth induced by asthmatic serumBy Michael Roth, Jun Zhong and Michael TammMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandJun Zhong1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, Switzerland
- Late-breaking abstract: Risk of endoscopic lung volume reduction in patients with previous lung surgery including lung volume reduction surgeryBy Peter Grendelmeier, Daiana Stolz, Didier Lardinois and Michael TammPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDidier Lardinois2Clinic of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Vasopressin in patients with obstructive sleep apnoea syndrome – An interventional, case-control studyBy Peter Grendelmeier, Werner Strobel, Thomas Schmid, Kathleen Jahn, Michael Tamm and Daiana StolzPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandWerner Strobel1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandThomas Schmid1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BALBy Eleni Papakonstantinou, Ioannis Klagas, Spyros Batzios, Michael Roth, Michael Tamm and Daiana StolzEleni Papakonstantinou1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandIoannis Klagas2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, GreeceSpyros Batzios2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, GreeceMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- PCR rapid molecular diagnostic assay for the diagnosis of bacterial infection in LRTI – A case-control, pilot studyBy Kathleen Jahn, Marko Kuisma, Mäki Minna, Peter Grendelmeier, Hans H. Hirsch, Michael Tamm and Daiana StolzKathleen Jahn1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMarko Kuisma1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMäki Minna1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandPeter Grendelmeier1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandHans H. Hirsch1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal diseaseBy Kristina Affolter, Michael Tamm, Kathleen Jahn, Jörg Halter, Jakob Passweg, Hans Hirsch and Daiana StolzKristina Affolter1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandJörg Halter1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandJakob Passweg1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandHans Hirsch1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Long-term data from the Swiss pulmonary hypertension registryBy Silvia Ulrich, Hans Stricker, Thomas Geiser, Stephan Keusch, Elisabeth Hasler, Peter Grendelmeier, Jean-Marc Fellrath, Frédéric Lador, Markus Schwerzmann, Daniel Weilenmann, Otto Schoch, Vladimir Popov, Thierry Rochat, Andrea Azzola, Maurice Beghetti, Laurent Nicod, Rudolf Speich, Lars Huber, Guido Domenighetti, John-David Aubert, Michael Tamm and Séverine Müller-MottetSilvia Ulrich1Pulmonary Clinic, University Hospital Zürich, Zürich, SwitzerlandHans Stricker2Internal Medicine, Ospedale la Carità, Locarno, SwitzerlandThomas Geiser5Pulmonary Clinic, University Hospital of Bern, Bern, SwitzerlandStephan Keusch1Pulmonary Clinic, University Hospital Zürich, Zürich, SwitzerlandElisabeth Hasler1Pulmonary Clinic, University Hospital Zürich, Zürich, SwitzerlandPeter Grendelmeier4Pulmonary Clinic, University Hospital of Basel, Basel, SwitzerlandJean-Marc Fellrath6Pulmonary Clinic, Cantonal Hospital Neuchatel, Neuchatel, SwitzerlandFrédéric Lador7Pulmonary Clinic, University Hospital of Geneva, Geneva, SwitzerlandMarkus Schwerzmann8Clinic for Cardiology, University Hospital of Bern, Bern, SwitzerlandDaniel Weilenmann9Clinic for Cardiology, Cantonal Hospital St.Gallen, St. Gallen, SwitzerlandOtto Schoch10Pulmonary Clinic, Cantonal Hospital St.Gallen, St. Gallen, SwitzerlandVladimir Popov11Pulmonary Clinic, Cantonal Hospital Lucerne, Lucerne, SwitzerlandThierry Rochat7Pulmonary Clinic, University Hospital of Geneva, Geneva, SwitzerlandAndrea Azzola3Pulmonary Clinic, Cantonal Hospital Lugano, Lugano, SwitzerlandMaurice Beghetti12Pediatric Cardiology Unit, University Children’s Hospital, Geneva, SwitzerlandLaurent Nicod13Pulmonary Clinic, University Hospital of Lausanne, Lausanne, SwitzerlandRudolf Speich14Internal Medicine, University Hospital Zürich, Zürich, SwitzerlandLars Huber1Pulmonary Clinic, University Hospital Zürich, Zürich, SwitzerlandGuido Domenighetti15Pulmonary Clinic, Cantonal Hospital Locarno, Locarno, SwitzerlandJohn-David Aubert13Pulmonary Clinic, University Hospital of Lausanne, Lausanne, SwitzerlandMichael Tamm4Pulmonary Clinic, University Hospital of Basel, Basel, SwitzerlandSéverine Müller-Mottet1Pulmonary Clinic, University Hospital Zürich, Zürich, Switzerland
- Bosentan does not improve outcome in patients with steroid-resistant pulmonary sarcoidosis – Results from a double-blind placebo-controlled phase 2 trialBy Katrin Hostettler, Florent Baty, Rebekka Kleiner, Lilian Junker, Michael Tamm and Martin BrutscheKatrin Hostettler1Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandFlorent Baty2Division of Pulmonary Medicine, Cantonal Hospital St.Gallen, St. Gallen, SwitzerlandRebekka Kleiner2Division of Pulmonary Medicine, Cantonal Hospital St.Gallen, St. Gallen, SwitzerlandLilian Junker1Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMartin Brutsche2Division of Pulmonary Medicine, Cantonal Hospital St.Gallen, St. Gallen, Switzerland
- Viral infection land lung function decline following lung transplantationBy Kathleen Jahn, Peter Grendelmeier, John David Aubert, Hans Hirsch, Daiana Stolz and Michael TammKathleen Jahn1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandPeter Grendelmeier1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandJohn David Aubert2Clinic of Pneumology, University Hospital Lausanne, Lausanne, SwitzerlandHans Hirsch3Microbiological Institute, University Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pneumology, University Hospital Basel, Basel, Switzerland
- Nintedanib (BIBF 1120) prevents TGF-β-induced pro-fibrotic effects in primary human lung myofibroblasts derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Jun Zhong, George Karakiulakis, Didier Lardinois, Michael Tamm and Michael RothKatrin Hostettler1Department of BioMedicine, University Hospital Basel, Basel, Switzerland2Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou3Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceJun Zhong1Department of BioMedicine, University Hospital Basel, Basel, SwitzerlandGeorge Karakiulakis3Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceDidier Lardinois4Division of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of BioMedicine, University Hospital Basel, Basel, Switzerland2Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of BioMedicine, University Hospital Basel, Basel, Switzerland
- Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohortBy Nebal Abu Hussein, Evelyne Sonderer, Pierre-Olivier Bridevaux, Prashant Chhajed, Jean-William Fitting, Thomas Geiser, Ladina Joos Zellweger, Malcolm Kohler, Sabrina Maier, David Miedinger, Salome Schafroth Tötök, Robert Thurnheer, Michael Tamm and Jörg Daniel LeuppiNebal Abu Hussein1Medical Research, University Clinic of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland2Medical Faculty, University of Basel, Basel, SwitzerlandEvelyne Sonderer2Medical Faculty, University of Basel, Basel, SwitzerlandPierre-Olivier Bridevaux3Department of Pneumology, University Hospital Geneva, Geneva, SwitzerlandPrashant Chhajed1Medical Research, University Clinic of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland2Medical Faculty, University of Basel, Basel, SwitzerlandJean-William Fitting4Department of Pneumology, University Hospital Lausanne, Lausanne, SwitzerlandThomas Geiser5Department of Pneumology, Inselspital Bern University Hospital, Berne, SwitzerlandLadina Joos Zellweger6Department of pneumology, Clara Hospital, Basel, SwitzerlandMalcolm Kohler7Department of Pneumology, Ûniversity Hospital Zurich, Zurich, SwitzerlandSabrina Maier1Medical Research, University Clinic of Internal Medicine, Cantonal Hospital Baselland, Liestal, SwitzerlandDavid Miedinger1Medical Research, University Clinic of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland2Medical Faculty, University of Basel, Basel, SwitzerlandSalome Schafroth Tötök8Department of Pneumology, University Hospital Basel, Basel, SwitzerlandRobert Thurnheer9Department of Pneumology, Cantonal Hospital Muensterlingen, Muensterlingen, SwitzerlandMichael Tamm8Department of Pneumology, University Hospital Basel, Basel, SwitzerlandJörg Daniel Leuppi1Medical Research, University Clinic of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland2Medical Faculty, University of Basel, Basel, Switzerland
- COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter studyBy Daiana Stolz, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Marin, Lucas Boeck, Janko Rakic, Andreas Scherr, Antoni Torres, Tobias Welte and Michael TammDaiana Stolz1Pneumology, University Hospital of Basel, Basel, SwitzerlandRenaud Louis7Pneumology CHU Liege, University of Liege, Liege, BelgiumWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrad, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Marin9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- COPD on anti-GERD therapy remains at higher risk for severe exacerbationBy Daiana Stolz, Francesco Blasi, Joachim Aerts, Renaud Louis, Branislava Milenkovic, Kostantinos Kostikas, Tobias Welte, Antoni Torres, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Wim Boersma and Michael TammDaiana Stolz1Pneumology, University Hospital of Basel, Basel, SwitzerlandFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsRenaud Louis7Pneumology CHU Liege, University of Liege, Liege, BelgiumBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrad, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatmentBy Eleni Papakonstantinou, Ioannis Klagas, George Karakiulakis, Spasenija Savic Prince, Michael Roth, Michael Tamm and Daiana StolzEleni Papakonstantinou1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, SwitzerlandIoannis Klagas2Departement of Pharmacology, School of Medicine A.U.T.H, Thessaloniki, GreeceGeorge Karakiulakis2Departement of Pharmacology, School of Medicine A.U.T.H, Thessaloniki, GreeceSpasenija Savic Prince3Department of Pathology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, Switzerland
- Single-breath washout in stable COPD patients: Association with bodyplethysmography and bronchodilator responseBy Anna Gensmer, Sylvia Nyilas, Michael Tamm, Philipp Latzin and Daiana StolzAnna Gensmer1Pneumology, University Children's Hospital, Basel, SwitzerlandSylvia Nyilas1Pneumology, University Children's Hospital, Basel, SwitzerlandMichael Tamm2Pneumology, University Hospital, Basel, SwitzerlandPhilipp Latzin1Pneumology, University Children's Hospital, Basel, SwitzerlandDaiana Stolz2Pneumology, University Hospital, Basel, Switzerland
- GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive dataBy Nebal Abu Hussein, Pascal Urwyler, P.O Bridevaux, P.N Chhajed, J.W. Fitting, Thomas Geiser, Ladina Joos Zellweger, Melcom Kohler, Sabrina Maier, David Miedinger, Salome Schafroth Török, Robert Thurnheer, Michael Tamm and Joerg Daniel LeuppiNebal Abu Hussein1Internal Medicine, Cantonal Hospital Baselland, Liestal, SwitzerlandPascal Urwyler2Medical Faculty, University of Basel, Basel, SwitzerlandP.O Bridevaux3Hôpitaux Universitaires de Genève, Hôpitaux Universitaires de Genève, Geneve, SwitzerlandP.N Chhajed4Pneumology Clinic, University Hospital Basel, Basel, SwitzerlandJ.W. Fitting5Centre Hospitalier Universitaire Vaudois, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandThomas Geiser6Inselspital Berne, Inselspital Berne, Berne, SwitzerlandLadina Joos Zellweger7St. Claraspital Hospital, St. Claraspital Hospital, Basel, SwitzerlandMelcom Kohler8University Hospital Zurich, University Hospital Zurich, Zurich, SwitzerlandSabrina Maier9Kantonsspital Muensterlingen, Kantonsspital Muensterlingen, Muensterlingen, SwitzerlandDavid Miedinger1Internal Medicine, Cantonal Hospital Baselland, Liestal, SwitzerlandSalome Schafroth Török1Internal Medicine, Cantonal Hospital Baselland, Liestal, SwitzerlandRobert Thurnheer1Internal Medicine, Cantonal Hospital Baselland, Liestal, SwitzerlandMichael Tamm2Medical Faculty, University of Basel, Basel, SwitzerlandJoerg Daniel Leuppi9Kantonsspital Muensterlingen, Kantonsspital Muensterlingen, Muensterlingen, Switzerland
- LATE-BREAKING ABSTRACT: Molecular diagnostics in the bronchoalveolar lavage in a large cohort of immunocompromised patientsBy Daiana Stolz, Reno Frei, Kathleen Jahn, Romana Calligaris-Maibach, Norina Reifer, Lilian Junker and Michael TammDaiana Stolz1Clinic of Pneumology, University Hospital, Basel, SwitzerlandReno Frei2Laboratory Medicine, University Hospital, Basel, SwitzerlandKathleen Jahn1Clinic of Pneumology, University Hospital, Basel, SwitzerlandRomana Calligaris-Maibach2Laboratory Medicine, University Hospital, Basel, SwitzerlandNorina Reifer1Clinic of Pneumology, University Hospital, Basel, SwitzerlandLilian Junker1Clinic of Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Clinic of Pneumology, University Hospital, Basel, Switzerland
- Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Qingzhu Sun, Michael Tamm, Christopher Lambers and Michael RothKatrin Hostettler1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceQingzhu Sun1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandChristopher Lambers3Department of Thoracic Surgery, Medical University Vienna, Vienna, AustriaMichael Roth1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Fungal PCR in the bronchoalveolar lavage for diagnosing invasive fungal diseaseBy Kristina Affolter, Kathleen Jahn, Elisabeth Wehrle-Wieland, Daniel Goldenberger, Michael Tamm, Nina Khanna, Daiana Stolz, Jörg Halter and Jakob PasswegKristina Affolter1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandKathleen Jahn1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandElisabeth Wehrle-Wieland2Clinic of Infectiology, University Hospital Basel, Basel, SwitzerlandDaniel Goldenberger2Clinic of Infectiology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandNina Khanna2Clinic of Infectiology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandJörg Halter1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, SwitzerlandJakob Passweg1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital of Basel, Basel, Switzerland
- Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Michael Tamm, Christopher Lambers, Didier Lardinois and Michael RothKatrin Hostettler1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Tamm1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandChristopher Lambers3Department of Thoracic Surgery, Medical University Vienna, Vienna, AustriaDidier Lardinois4Division of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPDBy Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, George Karakiulakis, Michael Roth, Michael Tamm and Daiana StolzEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandIoannis Klagas2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceGeorge Karakiulakis2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacityBy Jyotshna Mandal, Michael Roth, Eleni Papakonstantinou, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte and Daiana StolzJyotshna Mandal1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital Basel, Basel, SwitzerlandRenaud Louis2Pneumology, University of Liege, Liege, BelgiumBranislava Milencovic3Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma4Pneumology, Medisch Centrum, Alkmaar, NetherlandsKonstantinos Kostikas5Pneumology, Medical School, University of Thessaly, Larisa, GreeceFrancesco Blasi6Pneumology, IRCCS Policlinico Milan, Milan, ItalyJoachim Aerts7Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital Maastricht, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE studyBy Daiana Stolz, Jacob Hull Kristensen, Diana Julie Leeming, Morten Asser Karsdal, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr and Michael TammDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandJacob Hull Kristensen12Biomarkers and Research, Nordic Bioscience, Herlev, DenmarkDiana Julie Leeming12Biomarkers and Research, Nordic Bioscience, Herlev, DenmarkMorten Asser Karsdal12Biomarkers and Research, Nordic Bioscience, Herlev, DenmarkTobias Welte2Pneumology, Medizinische Hochschule, Hannover, GermanyAntoni Torres3Pneumology, Hospital Clinic, Barcelona, SpainRenaud Louis4Pneumology, University Hospital, Liege, BelgiumWim Boersma5Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic6Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaKonstantinos Kostikas7Pneumology, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi8Pneumology, IRCCS Polyclinico, Milan, ItalyJoachim Aerts9Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde10Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma11Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson scoreBy Eleni Papakonstantinou, Ioannis Bonovolias, Michael Roth, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Ioachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte and Daiana StolzEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandIoannis Bonovolias2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital Basel, Basel, SwitzerlandRenaud Louis3Pneumology, University of Liege, Liege, BelgiumBranislava Milencovic4Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma5Pneumology, Medisch Center, Alkmaar, NetherlandsKonstantinos Kostikas6Pneumology, Medical School, University of Thessaly, Larisa, GreeceFrancesco Blasi7Pneumology, IRCCS Policlinico, Milan, ItalyIoachim Aerts8Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde9Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma10Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte12Pneumology, Medizinische Hochschule, Hannover, GermanyDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cellsBy Jyotshna Mandal, Michael Roth, Lukas Bubendorf, Spasenija Savic, Michael Tamm and Daiana StolzJyotshna Mandal1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandLukas Bubendorf2Institute for Pathology, University Hospital Basel, Basel, SwitzerlandSpasenija Savic2Institute for Pathology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pneumology, University Hospital Basel, Basel, Switzerland
- Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk indexBy Lucas Boeck, Kostantinos Kostikas, Francesco Blasi, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim Aerts, Tobias Welte, Antoni Torres, Gernot Rohde, Janko Rakic, Andreas Scherr, Michael Koller, Michael Tamm and Daiana StolzLucas Boeck1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandKostantinos Kostikas2Department of Pneumology, University Thessaly Medical School, Larissa, GreeceFrancesco Blasi3Department of Pathophysiology and Transplantation, Universita' degli Studi di Milano, Milan, ItalyWim Boersma4Department of Pneumology, Medisch Centrum Alkmaar, Alkmaar, NetherlandsBranislava Milenkovic5Clinic for Pulmonary Diseases, Faculty of Medicine, University of Belgrade, Belgrade, SerbiaAlicia Lacoma6Department of Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainRenaud Louis7Department of Pneumology, CHU Liege, University of Liege, GIGAI Research Group, Liege, BelgiumJoachim Aerts8Department of Pneumology, Amphia Hospital/Erasmus MC, Breda, NetherlandsTobias Welte9Department of Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyAntoni Torres10Department of Pneumology, Hospital Clinic - IDIBAPS, Ciber de Enfermedades Respiratorias, Barcelona, SpainGernot Rohde11Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, NetherlandsJanko Rakic1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Koller12Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Department of Pneumology, University Hospital Basel, Basel, Switzerland
- Characterizations and potential functions of protein arginine methyltransferase 1 in primary lung structural cellsBy Qingzhu Sun, Daiana Stolz, Michael Tamm, Shemin Lu and Michael RothQingzhu Sun1Department of Biomedicine, University Hospital Basel, Basel, Switzerland2Department of Biochemistry and Molecular Biology, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi ChinaDaiana Stolz1Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandShemin Lu2Department of Biochemistry and Molecular Biology, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi ChinaMichael Roth1Department of Biomedicine, University Hospital Basel, Basel, Switzerland
- Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Chistopher Lambers, Michael Tamm and Michael RothKatrin Hostettler1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceChistopher Lambers3Department of Thoracic Surgery, Medical University Vienna, Vienna, AustriaMichael Tamm1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPDBy Jyotshna Mandal, Michael Roth, Luigi Costa, Lucas Boeck, Eleni Papakonstantinou, Michael Tamm and Daiana StolzJyotshna Mandal1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandLuigi Costa1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Pneumology, University Thessaly Medical School, Larissa, GreeceMichael Tamm1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pneumology, University Hospital Basel, Basel, Switzerland
- Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patientsBy Bijaya Malla, Jyotshna Mandal, Luigi Costa, Rudi Steffensen, Adrian Egli, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm, Michael Roth and Daiana StolzBijaya Malla1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandJyotshna Mandal1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandLuigi Costa1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandRudi Steffensen2Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandAdrian Egli3Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandTobias Welte4Department of Clinical Immunology, Aalborg University Hospital, Aalborg, DenmarkAntoni Torres5Infection Biology, Department of Biomedicine, University of Basel, Basel, SwitzerlandRenaud Louis6Pneumology, Medizinische Hochschule, Hannover, GermanyWim Boersma7Pneumology, Hospital Clinic, Barcelona, SpainBranislava Milenkovic8Pneumology, University of Liege, Liege, BelgiumKostantinos Kostikas9Pneumology, Medisch Centrum, Alkmaar, NetherlandsFrancesco Blasi10Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaJoachim Aerts11Pneumology, Thessaly Medical School, Thessaloniki, GreeceGernot Rohde12Pneumology, IRCCS Policlinico, Milan, ItalyAlicia Lacoma13Pneumology, Amphia Hospital, Breda, NetherlandsLucas Boeck14Pneumology, University Hospital, Maastricht, NetherlandsJanko Rakic14Pneumology, University Hospital, Maastricht, NetherlandsAndreas Scherr14Pneumology, University Hospital, Maastricht, NetherlandsMichael Tamm14Pneumology, University Hospital, Maastricht, NetherlandsMichael Roth1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandDaiana Stolz14Pneumology, University Hospital, Maastricht, Netherlands
- Prognostic assessment in COPD without lung function: the B-AE-D indicesBy Lucas Boeck, Joan B. Soriano, Marjolein Brusse-Keizer, Francesco Blasi, Konstantinos Kostikas, Wim Boersma, Branislava Milenkovic, Renaud Louis, Alicia Lacoma, Remco Djamin, Joachim Aerts, Antoni Torres, Gernot Rohde, Tobias Welte, Pablo Martinez-Camblor, Janko Rakic, Andreas Scherr, Michael Koller, Job van der Palen, Jose M. Marin, Inmaculada Alfageme, Pere Almagro, Ciro Casanova, Cristobal Esteban, Juan J. Soler-Cataluña, Juan P. de Torres, Marc Miravitlles, Bartolome R. Celli, Michael Tamm and Daiana StolzArticle | Published in 2016 in European Respiratory JournalLucas Boeck1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandJoan B. Soriano2Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónoma de Madrid, Cátedra UAM-Linde, Madrid, SpainMarjolein Brusse-Keizer3Medical School Twente, Medisch Spectrum Twente, Enschede, The NetherlandsFrancesco Blasi4Dept of Pathophysiology and Transplantation, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Cà Granda, Milan, ItalyKonstantinos Kostikas5University of Thessaly Medical School, Larissa, GreeceWim Boersma6Dept of Pneumology, Medisch Centrum, Alkmaar, The NetherlandsBranislava Milenkovic7Faculty of Medicine, University of Belgrade, Belgrade, Serbia8Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Belgrade, SerbiaRenaud Louis9Dept of Pneumology, University of Liege, Liege, BelgiumAlicia Lacoma10Dept of Microbiology, Hospital Universitari Germans Trias i Pujol, CIBER Enfermedades Respiratorias, Badalona, SpainRemco Djamin11Dept of Pneumology, Amphia Hospital, Breda, The NetherlandsJoachim Aerts11Dept of Pneumology, Amphia Hospital, Breda, The NetherlandsAntoni Torres12Dept of Pneumology, Hospital Clinic, Barcelona, SpainGernot Rohde13Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The NetherlandsTobias Welte14Dept of Pneumology, Medizinische Hochschule, Hannover, GermanyPablo Martinez-Camblor15Universidad Autónoma de Chile, Santiago, ChileJanko Rakic1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandAndreas Scherr1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandMichael Koller16Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, SwitzerlandJob van der Palen3Medical School Twente, Medisch Spectrum Twente, Enschede, The NetherlandsJose M. Marin17Respiratory Dept, Hospital Universitario Miguel Servet, Zaragoza, SpainInmaculada Alfageme18Respiratory Dept, Valme University Hospital, Seville, SpainPere Almagro19Internal Medicine Unit, Hospital Universitari Mútua de Terrassa, Barcelona, SpainCiro Casanova20Respiratory Dept, Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, SpainCristobal Esteban21Respiratory Dept, Hospital Galdakao-Usansolo, Bizkaia, SpainJuan J. Soler-Cataluña22Respiratory Unit, Hospital General de Requena, Valencia, SpainJuan P. de Torres23Respiratory Dept, Clínica Universidad de Navarra, Pamplona, SpainMarc Miravitlles24Pneumology Dept, Hospital Universitari Vall d'Hebron, Barcelona, SpainBartolome R. Celli25Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard University, Boston, MA, USAMichael Tamm1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, Switzerland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.